{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Multivalent&page=2", "query": { "intervention": "Multivalent", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Multivalent&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-03T02:35:03.151Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06431607", "title": "A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza, Human" ], "interventions": [ { "name": "F2G22B/DL001Z", "type": "BIOLOGICAL" }, { "name": "F2H23D/DL001Z-NH", "type": "BIOLOGICAL" }, { "name": "F2H23B/DL001Z-NH", "type": "BIOLOGICAL" }, { "name": "F2H23H/DL001Z", "type": "BIOLOGICAL" }, { "name": "FDQ23A-NH (Flu D-QIV)", "type": "COMBINATION_PRODUCT" }, { "name": "GSK5800544A", "type": "BIOLOGICAL" }, { "name": "Flu D-TIV", "type": "COMBINATION_PRODUCT" }, { "name": "F2H23A/DL001Z-NH", "type": "BIOLOGICAL" }, { "name": "F2H23G/DL001Z", "type": "BIOLOGICAL" }, { "name": "Fluzone HD Quadrivalent", "type": "COMBINATION_PRODUCT" }, { "name": "Fluzone HD", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "BIOLOGICAL", "COMBINATION_PRODUCT" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 845, "start_date": "2024-05-23", "completion_date": "2025-06-04", "has_results": true, "last_update_posted_date": "2026-03-10", "last_synced_at": "2026-09-03T02:35:03.151Z", "location_count": 18, "location_summary": "Hialeah, Florida • Miami, Florida • Chicago, Illinois + 14 more", "locations": [ { "city": "Hialeah", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Valparaiso", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT06431607" }, { "nct_id": "NCT07160244", "title": "BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Multivalent Group B streptococcus vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "Infanrix hexa", "type": "BIOLOGICAL" }, { "name": "Prevenar 20", "type": "BIOLOGICAL" }, { "name": "Pediarix", "type": "BIOLOGICAL" }, { "name": "Prevnar 20", "type": "BIOLOGICAL" }, { "name": "Infanrix", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "1 Day", "maximum_age": "49 Years", "sex": "ALL", "summary": "1 Day to 49 Years" }, "enrollment_count": 6000, "start_date": "2025-08-25", "completion_date": "2029-03-02", "has_results": false, "last_update_posted_date": "2026-08-24", "last_synced_at": "2026-09-03T02:35:03.151Z", "location_count": 119, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Mobile, Alabama + 57 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT07160244" }, { "nct_id": "NCT00392015", "title": "NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Plasmodium Falciparum" ], "interventions": [ { "name": "NMRC-M3V-Ad-PfCA", "type": "BIOLOGICAL" }, { "name": "NMRC-MV-Ad-PfC, NMRC-M3V-Ad-PfCA", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "U.S. Army Medical Research and Development Command", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 59, "start_date": "2006-10-12", "completion_date": "2017-09-25", "has_results": true, "last_update_posted_date": "2021-05-21", "last_synced_at": "2026-09-03T02:35:03.151Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00392015" }, { "nct_id": "NCT06907849", "title": "124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lumbar Spinal Stenosis", "Carpal Tunnel Syndrome (CTS)", "Cardiac Amyloidosis" ], "interventions": [ { "name": "124I-evuzamitide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Tennessee Graduate School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 40, "start_date": "2025-05-22", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-07-21", "last_synced_at": "2026-09-03T02:35:03.151Z", "location_count": 1, "location_summary": "Knoxville, Tennessee", "locations": [ { "city": "Knoxville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT06907849" }, { "nct_id": "NCT04801420", "title": "Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Pediatric And Adult Study Population", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lyme Borreliosis" ], "interventions": [ { "name": "VLA15", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "5 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "5 Years to 65 Years" }, "enrollment_count": 625, "start_date": "2021-03-08", "completion_date": "2025-07-02", "has_results": true, "last_update_posted_date": "2026-05-19", "last_synced_at": "2026-09-03T02:35:03.151Z", "location_count": 19, "location_summary": "Bridgeport, Connecticut • Stamford, Connecticut • Waterbury, Connecticut + 12 more", "locations": [ { "city": "Bridgeport", "state": "Connecticut" }, { "city": "Stamford", "state": "Connecticut" }, { "city": "Waterbury", "state": "Connecticut" }, { "city": "Waterbury", "state": "Connecticut" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04801420" }, { "nct_id": "NCT04199689", "title": "Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Papillomavirus Infections" ], "interventions": [ { "name": "9vHPV Vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo (Saline for Injection)", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "20 Years to 45 Years · Male only" }, "enrollment_count": 6033, "start_date": "2020-02-27", "completion_date": "2028-08-31", "has_results": false, "last_update_posted_date": "2025-03-25", "last_synced_at": "2026-09-03T02:35:03.151Z", "location_count": 32, "location_summary": "Northridge, California • Rialto, California • Simi Valley, California + 28 more", "locations": [ { "city": "Northridge", "state": "California" }, { "city": "Rialto", "state": "California" }, { "city": "Simi Valley", "state": "California" }, { "city": "Spring Valley", "state": "California" }, { "city": "Walnut Creek", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04199689" }, { "nct_id": "NCT05968846", "title": "Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Systemic Amyloidosis" ], "interventions": [ { "name": "Injection of peptide p5+14 radiolabeled with iodine-124 (124I-AT-01)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Tennessee Graduate School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 19, "start_date": "2022-12-07", "completion_date": "2023-09-01", "has_results": true, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-09-03T02:35:03.151Z", "location_count": 1, "location_summary": "Knoxville, Tennessee", "locations": [ { "city": "Knoxville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT05968846" }, { "nct_id": "NCT07086677", "title": "A Study to Learn About How a New Pneumococcal Vaccine Works in Adults", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Streptococcus Pneumoniae" ], "interventions": [ { "name": "PG4 vaccine in Buffer 1 with low dose PA-001", "type": "BIOLOGICAL" }, { "name": "PG4 in Buffer 1 with low dose PA-002", "type": "BIOLOGICAL" }, { "name": "PG4 in Buffer 1 with high dose PA-001", "type": "BIOLOGICAL" }, { "name": "PG4 vaccine in Buffer 1 with high dose PA-002", "type": "BIOLOGICAL" }, { "name": "PG4 vaccine in Buffer 2", "type": "BIOLOGICAL" }, { "name": "20-valent pneumococcal conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "Saline injection", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "65 Years to 84 Years" }, "enrollment_count": 380, "start_date": "2025-07-22", "completion_date": "2027-10-21", "has_results": false, "last_update_posted_date": "2026-06-22", "last_synced_at": "2026-09-03T02:35:03.151Z", "location_count": 20, "location_summary": "Lake Forest, California • Rolling Hills Estates, California • Greenacres City, Florida + 13 more", "locations": [ { "city": "Lake Forest", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "Greenacres City", "state": "Florida" }, { "city": "Miami Lakes", "state": "Florida" }, { "city": "Lenexa", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07086677" }, { "nct_id": "NCT00784524", "title": "Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "allogeneic large multivalent immunogen breast cancer vaccine", "type": "BIOLOGICAL" }, { "name": "aldesleukin", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 14, "start_date": "2008-09", "completion_date": "2014-07", "has_results": true, "last_update_posted_date": "2019-06-06", "last_synced_at": "2026-09-03T02:35:03.151Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00784524" }, { "nct_id": "NCT03512288", "title": "Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pneumococcal Infections" ], "interventions": [ { "name": "Multivalent", "type": "BIOLOGICAL" }, { "name": "13vPnC", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "98 Days", "sex": "ALL", "summary": "42 Days to 98 Days" }, "enrollment_count": 460, "start_date": "2018-04-16", "completion_date": "2020-02-11", "has_results": true, "last_update_posted_date": "2021-03-02", "last_synced_at": "2026-09-03T02:35:03.151Z", "location_count": 39, "location_summary": "Fayetteville, Arkansas • Downey, California • Huntington Beach, California + 29 more", "locations": [ { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Downey", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Ontario", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03512288" } ] }